BRUKER CORPORATION (NASDAQ:BRKR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

ME Staff 8-k
-
0

BRUKER CORPORATION (NASDAQ:BRKR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March12, 2018, the Board of Directors of Bruker Corporation (“Bruker,” the “Company,” “we” or “us”) appointed Gerald N. Herman to serve as the Company’s Interim Chief Financial Officer, effective as of March17, 2018 upon the departure of Chief Financial Officer and Senior Vice President Anthony L. Mattacchione. Mr.Mattacchione’s resignation was previously reported in the Company’s Form8-K filed with the Securities and Exchange Commission on February21, 2018. Mr.Herman, age 60, joined the Company in 2016 as Vice President and Corporate Controller and currently serves as principal accounting officer. Upon commencement of his service as Interim Chief Financial Officer, Mr.Herman also will serve as the Company’s principal financial officer.

Prior to joining the Company, Mr.Herman was Corporate Vice President – Clinical Operations of PAREXEL International from 2014 to February2016 and Corporate Vice President& Controller-Finance of PAREXEL from 2008 to 2013. From 2005 to 2008, Mr.Herman was Vice President-Corporate Controller of Presstek,Inc. Prior to 2005, he served in a variety of financial and accounting roles at various organizations, including as Senior Manager at Arthur Andersen LLP from 1979 to 1987. Mr.Herman is a Certified Public Accountant in the Commonwealth of Massachusetts and holds a M.B.A. from the University of Chicago and a Master of Science in Taxation from Bentley University.

There is no arrangement or understanding between Mr.Herman and any other person to which Mr.Herman was appointed as Interim Chief Financial Officer of the Company. There are no transactions in which Mr.Herman has an interest requiring disclosure under Item 404(a)of Regulation S-K.

In connection with his appointment as Interim Chief Financial Officer, Mr.Herman’s base salary of $250,000 will be increased by $6,000 per month from the effective date of his appointment. Additionally, he will be eligible to receive a special bonus, payable in April2019, in the amount of either $100,000 if selected as the Company’s permanent Chief Financial Officer or $150,000 if an external candidate is appointed to that position, subject to continuation of employment and achievement of certain goals.

A copy of the Company’s press release announcing Mr.Herman’s appointment is attached as Exhibit99.1 to this Current Report on Form8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Number

99.1

Press release dated March14, 2018.


BRUKER CORP Exhibit
EX-99.1 2 a18-8257_1ex99d1.htm EX-99.1 Exhibit 99.1     Bruker Appoints Gerald Herman as Interim Chief Financial Officer   BILLERICA,…
To view the full exhibit click here

About BRUKER CORPORATION (NASDAQ:BRKR)

Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive (CBRNE) detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.